Copernicium Pharmaceuticals Private Limited
About Copernicium Pharmaceuticals Private Limited
Data last updated:
Copernicium Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 10 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2013PTC072419. Its GSTIN is 29AAFCC5033K1ZJ (Karnataka).
The company has an authorised share capital of ₹3.6 Cr and a paid-up capital of ₹3.58 Cr. It is led by directors Salim Sadiq Shaikh and Akash Suresh Puranik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.15 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹2.82 Cr (net margin 45.8%) and EBITDA of ₹4.26 Cr (EBITDA margin 69.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 10% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹29.21 Cr on record. The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹1.14 Cr; the latest was in March 2022.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Copernicium Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSree Veerabhadreshwara Swamy Enclave No. 1215 24th Main 11th Cross Hsr Layout 1st S, Ector, Bangalore, Karnataka, India – 560102
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Copernicium Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Copernicium Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Copernicium Pharmaceuticals Private Limited, buy the company report.
Financials of Copernicium Pharmaceuticals Private Limited
FY 2025 filings availableCopernicium Pharmaceuticals Private Limited reported revenue of ₹6.15 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 5% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 69.3% | ||||
| Net Profit Margin | 45.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Copernicium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Copernicium Pharmaceuticals Private Limited
Copernicium Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Salim Sadiq Shaikh Also directs: VPL Chemicals Private Limited, Sequent Penems Private Limited, Anveta Therapeutics Private Limited and 5 more | Director | 10 Dec 2013 | 12 Years 10 Months | Current |
| Akash Suresh Puranik Also directs: VPL Chemicals Private Limited, Sequent Penems Private Limited, Symbio Generrics India Private Limited and 1 more | Director | 23 Dec 2013 | 12 Years 10 Months | Current |
Auditor
Copernicium Pharmaceuticals Private Limited is audited by K KISHORE & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K KISHORE & CO | FY 2021 | 011580S |
Shareholding
The shareholding of Copernicium Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Copernicium Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Nov 2022 | 100649377 | Others | ₹28 Cr | Open | |
| 01 Sep 2021 | 100478369 | Hdfc Bank Limited | ₹29.72 Lakh | Open | |
| 16 Sep 2020 | 100429488 | Hdfc Bank Limited | ₹10 Lakh | Open | |
| 28 Aug 2020 | 100429490 | Hdfc Bank Limited | ₹10 Lakh | Open | |
| 28 Aug 2020 | 100429611 | Hdfc Bank Limited | ₹37.01 Lakh | Open |
To see the full charge records of Copernicium Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Copernicium Pharmaceuticals Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹1.14 Cr; the latest was in March 2022.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Funding round · Series A | ₹1.14 Cr | Investors: Symbio Generrics India Private Limited |
| Feb 2022 | Rights issue | ₹1.28 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Copernicium Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Copernicium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Copernicium Pharmaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Copernicium Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCC5033K1ZJ | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Copernicium Pharmaceuticals Private Limited, buy the company report.
Recent activity
Copernicium Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Abhijit Govindrao Kale ceased to be Director on 30 Mar 2022.
1 earlier event is in the company report.
Frequently asked questions
Copernicium Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 10 December 2013 (13+ years old) and is registered under CIN U24230KA2013PTC072419.
Copernicium Pharmaceuticals has 2 current directors:
- Salim Sadiq Shaikh - Director
- Akash Suresh Puranik - Director
The latest financial statements of Copernicium Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Copernicium Pharmaceuticals is 29AAFCC5033K1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Copernicium Pharmaceuticals is U24230KA2013PTC072419. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Copernicium Pharmaceuticals was incorporated on 10 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
Copernicium Pharmaceuticals has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹1.14 Cr; the latest was in March 2022.
Abhijit Govindrao Kale ceased to be Director on 30 Mar 2022. Akash Suresh Puranik was appointed as Director on 23 Dec 2013. Salim Sadiq Shaikh was appointed as Director on 10 Dec 2013.
The registered office of Copernicium Pharmaceuticals is at Sree Veerabhadreshwara Swamy Enclave No. 1215 24th Main 11th Cross Hsr Layout 1st S, Ector, Bangalore, Karnataka, India – 560102.
Copernicium Pharmaceuticals operates in the business outsourcing industry, in the business and IT consulting segment.